Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer, June 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 152 articles: HTML format

Single Articles

1. ACAR U, Barlas F, Beyazgul B, Koruk I, et al
   Health belief model-based determinants of women's participation in cervical cancer screening: a case-control study from Southeastern Turkey.
   BMC Womens Health. 2026 May 30. doi: 10.1186/s12905-026-04582.
   PubMed    
   Abstract available
   
   

2. TESHALE MM, Kebede WM, Sahilu WT, Wondimu KS, et al
   Depression among women with cervical cancer: a systematic review and meta-analysis of available evidence.
   BMC Psychiatry. 2026 May 29. doi: 10.1186/s12888-026-08211.
   PubMed    
   Abstract available
   
   

3. CHEN Q, Lyu J, Li Y, Zhang L, et al
   Spatial transcriptomics of cervical cancer reveals microenvironment shaped the malignant epithelial programs and ECM-associated immune niches.
   Cancer Immunol Immunother. 2026 May 29. doi: 10.1007/s00262-026-04439.
   PubMed    
   Abstract available
   
   

4. WILKINS K, David O, Oguntoyinbo JO, Zainab H, et al
   Potential use of HOTAIR and MALAT1 as prognostic biomarkers for cervical cancer: An application to the NHS.
   Cancer Treat Res Commun. 2026;48:101256.
   PubMed    
   Abstract available
   
   

5. MOORTHY A, Le NA, Issac A, Willmott L, et al
   Brachytherapy use in cervical cancer: a narrative review.
   Gynecol Pelvic Med. 2026;9:8.
   PubMed    
   Abstract available
   
   

6. ZHANG J, Wei W, Zhang Y, Wang D, et al
   Metabolic reprogramming of cholesterol biosynthesis drives macrophage-mediated immune suppression in HPV-negative cervical adenocarcinoma.
   Front Immunol. 2026;17:1808107.
   PubMed    
   Abstract available
   
   

7. GOULIARIS M, Papalaskari A, Katsapanteras P, Zoglopitou L, et al
   Cervical Cancer Brachytherapy Dose Escalation Protocol: Analysis of Early Data Treatments According to EMBRACE II Protocol.
   Cureus. 2026;18:e107803.
   PubMed    
   Abstract available
   
   

8. YAN T, Ma Q, Shi H, Qi D, et al
   Disease burden of cervical cancer in China from 1990 to 2023 and prediction of future trends.
   Front Oncol. 2026;16:1802330.
   PubMed    
   Abstract available
   
   

9. VAJDA G, Loczi L, Vida B, Merkely P, et al
   Systemic inflammatory ratios and their added value to cytology in cervical cancer detection: a multicenter study.
   Front Med (Lausanne). 2026;13:1802477.
   PubMed    
   Abstract available
   
   

10. MAKIN J, Elishaev E, Durbin SM, Makin RA, et al
    Diagnostic Accuracy of Entropy Based Image Analysis of Cervical Precancerous Cells.
    J Biophotonics. 2026;19:e70294.
    PubMed    
    Abstract available
    
    

11. YAMAMOTO R, Asano H, Hatanaka KC, Shinomiya Y, et al
    Feasibility study of photoimmunotherapy combination with ASP-1929 for vulvar, vaginal, and cervical cancer.
    J Gynecol Oncol. 2026 May 21. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available
    
    

12. HWANG JH, Kim H
    Comparison of clinical outcomes between early and delayed diagnosis of cervical cancer following abnormal Pap smear results: a population-based cohort study using National Health Insurance data in South Korea.
    J Gynecol Oncol. 2026 May 26. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available
    
    

13. MA J, Wang G, Wang W, Yang H, et al
    Extended-field intensity-modulated radiation therapy and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic or common iliac lymph nodes: a multicenter prospective cohort study.
    J Gynecol Oncol. 2026 May 26. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available
    
    

14. WU J, Yi J, Fang L, Lei S, et al
    Urban-rural disparities in HPV prevalence and genotype distribution: a large-scale cervical cancer screening study in Xi'an, China.
    BMC Infect Dis. 2026 May 28. doi: 10.1186/s12879-026-13647.
    PubMed    
    Abstract available
    
    

15. LIU J, Jiao Y, Wang J, Cui X, et al
    miR-141-5p positively regulates ACVRL1 expression to promote cervical cancer progression.
    Hum Cell. 2026;39:81.
    PubMed    
    Abstract available
    
    

16. MOORTHY S, Raj EH, Sundersingh S, Raja A, et al
    Radiation-induced Osteosarcoma of the vaginal vault following cervical cancer treatment.
    BMJ Case Rep. 2026;19:e269768.
    PubMed    
    Abstract available
    
    

17. SACHIT BA, Dass S, Rajan RS, Tye GJ, et al
    Development and characterization of novel T-cell receptor-like antibodies targeting human papillomavirus type 16 oncoprotein peptides for early cervical cancer detection using experimental and computational approaches.
    Int J Biol Macromol. 2026 May 27:152755. doi: 10.1016/j.ijbiomac.2026.152755.
    PubMed    
    Abstract available
    
    

18. ZHANG Y, Wu Y, Yuan J, Yang J, et al
    A Longitudinal Qualitative Study on the Perioperative Symptom-Demand Journey Map of Patients with Cervical Cancer.
    Int J Womens Health. 2026;18:603381.
    PubMed    
    Abstract available
    
    

19. PATRA S, Shand H, Ghorai S
    Beyond conventional therapies: immunotherapeutic strategies targeting HPV-associated cervical cancer.
    Immunotherapy. 2026 May 27:1-21. doi: 10.1080/1750743X.2026.2679883.
    PubMed    
    Abstract available
    
    

20. WANG H, Zhu Y, Zhang B, Ding H, et al
    Promoting cervical cancer screening participation among Chinese women from resource-limited settings: a multicenter qualitative study.
    BMC Womens Health. 2026 May 27. doi: 10.1186/s12905-026-04546.
    PubMed    
    Abstract available
    
    

21. LYU Q, Zhao J, Chen Y, Xiong J, et al
    Molecular characterization of HPV integrations in high-risk HPV-positive women and development of a prognostic signature based on integration-associated genes for cervical cancer.
    Infect Agent Cancer. 2026 May 27. doi: 10.1186/s13027-026-00766.
    PubMed    
    Abstract available
    
    

22. CHEN L, Lin W, Huang Y, Li C, et al
    Spatiotemporal mapping of CD112 unveils its dichotomous role in T-cell exhaustion and ferroptosis crosstalk in cervical cancer.
    Cell Death Dis. 2026 May 27. doi: 10.1038/s41419-026-08902.
    PubMed    
    Abstract available
    
    

23. WANG J, Tu Y, Chen Y, Luo L, et al
    Cumulative dose assessment in combined radiotherapy for locally advanced cervical cancer using deformable image registration framework based on BTV dose uniformity.
    Brachytherapy. 2026 May 27:S1538-4721(26)00070.
    PubMed    
    Abstract available
    
    

24. LING HJ, Zhou JL, Cao LQ, Li R, et al
    TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting process.
    Cancer Genet. 2026;306-307:34-48.
    PubMed    
    Abstract available
    
    

25. ZHANG C, Meng Q, Jiao H, Liu H, et al
    HNRNPU K181 Lactylation Drives Cervical Cancer Growth by Upregulating PHGDH and Reprogramming Serine Metabolism.
    Adv Sci (Weinh). 2026 May 27:e20222. doi: 10.1002/advs.202520222.
    PubMed    
    Abstract available
    
    

26. XU C, Li H, Wu Y, Yao Q, et al
    Investigation of the clinical value of artificial intelligence-derived prognostic signature in cervical cancer based on machine learning algorithms.
    Discov Oncol. 2026 May 27. doi: 10.1007/s12672-026-05182.
    PubMed    
    Abstract available
    
    

27. LUPKOWSKI R, Gorniak K, Lisik-Habib M, Burchardt E, et al
    Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer-Data from the Polish-Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature.
    Antibodies (Basel). 2026;15:42.
    PubMed    
    Abstract available
    
    

28. FARRUKH S, Kavcic N, Canarutto G, Piazza S, et al
    Rethinking residual p53 function in HPV-positive cervical cancer cells.
    J Virol. 2026 May 27:e0047925. doi: 10.1128/jvi.00479.
    PubMed    
    Abstract available
    
    

29. WEI Y, Song F, Wang W
    Expression levels of serum SCC, HE4, and TSGF in cervical cancer patients and their correlation with recurrence: a retrospective study.
    Front Med (Lausanne). 2026;13:1813161.
    PubMed    
    Abstract available
    
    

30. TULIMILLI SV, Karnik M, Cockroft S, Bettadapura ADS, et al
    Recent advancements in the application of artificial intelligence-based approaches for screening, diagnosis, prognosis and treatment of cervical cancer.
    Oncol Rev. 2026;20:1760156.
    PubMed    
    Abstract available
    
    

31. NAKASI R, Wamozo C, Nsumba S, Rukundo B, et al
    Adapting DeepLabV3+ for biopsy cervical cancer lesion segmentation.
    Front Digit Health. 2026;8:1776155.
    PubMed    
    Abstract available
    
    

32. MISAWA Y, Mizuno S, Honda S, Shinohara R, et al
    Koilocytosis in LSIL Cytology Has Limited Predictive Value for CIN2+ in HPV-Positive Women: Implications for Risk-Based Cytology Triage.
    Pathogens. 2026;15:537.
    PubMed    
    Abstract available
    
    

33. BONIFACIO-VELEZ DE VILLA E, Aguilar-Luis MA, Silva-Caso W, Becerra-Goicochea L, et al
    Genetic Variability and Conserved T-Cell Epitope Prediction of the HPV16 E1 Protein in Cervix Samples from Peru.
    Pathogens. 2026;15:526.
    PubMed    
    Abstract available
    
    

34. ABASI X, Liang D, Rezhake R, Tuerxun G, et al
    Mechanism of Xiao-ai-fei Honey Ointment, a Traditional Uyghur Multi-Ingredient Medicinal Preparation, Against Cervical Cancer Based on Network Pharmacology and In Vitro Evaluation of Anti-Cancer Activity.
    Pharmaceuticals (Basel). 2026;19:686.
    PubMed    
    Abstract available
    
    

35. MUSHASHA MP, Modiba LM
    Strategies to Raise Awareness About Screening and Vaccination for the Human Papillomavirus Among Women in Limpopo Province, South Africa.
    Int J Environ Res Public Health. 2026;23:657.
    PubMed    
    Abstract available
    
    

36. WANG L, Ouyang Y, Zhao Q, Wang T, et al
    The Mechanism of Mg(2+)-Mediated Inhibition of Cervical Cancer by Inducing a Senescence-like State via the ATM/CHK2/p21 Signaling Pathway.
    Int J Mol Sci. 2026;27:4397.
    PubMed    
    Abstract available
    
    

37. PAWLIK P, Kurzawinska G, Ozarowski M, Karpinski TM, et al
    Genetic Variations in the Fibronectin 1 Gene (FN1) and Risk of Female Reproductive Cancers-A Preliminary Study.
    Int J Mol Sci. 2026;27:4302.
    PubMed    
    Abstract available
    
    

38. JABLONSKA IA, Golawski M, Scieglinska D, Kacorzyk U, et al
    Prognostic Value of Pretreatment Circulating Tumor HPV DNA Load in HPV-Associated Cancers: A Systematic Review and Meta-Analysis.
    Int J Mol Sci. 2026;27:4263.
    PubMed    
    Abstract available
    
    

39. SONGUR DAGLI S, Altun M
    Acceptability of HPV Self-Sampling for Cervical Cancer Screening Among Previously Screened Women in Turkiye: A Cross-Sectional Study.
    Healthcare (Basel). 2026;14:1312.
    PubMed    
    Abstract available
    
    

40. GARCIA-BERNAL JR, Resendiz-Castillo LJ, Martinez-Barajas MG, Diaz-Palomera CD, et al
    Differential Protumoral Mechanisms Induced by CAFs in Cervical Cancer Cells Occur Independently of 17beta-Estradiol Stimulation.
    Cancers (Basel). 2026;18:1509.
    PubMed    
    Abstract available
    
    

41. SUN C, Chu A, Liu S, Song R, et al
    Prediction of myelosuppression in cervical cancer after concurrent chemoradiotherapy by CT radiomics-based model.
    BMC Med Imaging. 2026 May 26. doi: 10.1186/s12880-026-02435.
    PubMed    
    Abstract available
    
    

42. BUSAYO SE, Adewale FL, Ogundokun RO, Adewale OF, et al
    Knowledge and Perception of Cervical Cancer and Pap-Smear Screening Among Antenatal Women in Ogun State, Nigeria.
    Cancer Med. 2026;15:e71949.
    PubMed    
    Abstract available
    
    

43. LIU Y, Wu R, Li C, Li R, et al
    Systematic photodynamic therapy for concurrent cervical-vaginal high-grade squamous intraepithelial lesion: a series of eight cases.
    Lasers Med Sci. 2026;41:102.
    PubMed    
    Abstract available
    
    

44. ZHANG Z, Bussmann H, Vong S, Kol H, et al
    A Micro-costing Study of Community-Based Primary HPV Self-Sampling and Triage Test for Cervical Cancer Screening in Rural Cambodia.
    Pharmacoecon Open. 2026 May 26. doi: 10.1007/s41669-026-00659.
    PubMed    
    Abstract available
    
    

45. SUSILADEWI IAMV, Afiyanti Y, Allenidekania A, Fitch M, et al
    Perceptions and Behaviors of Healthcare Providers Regarding Sexuality in Cervical Cancer Care: A Qualitative Study.
    Curr Oncol. 2026;33:253.
    PubMed    
    Abstract available
    
    

46. ZHANG H, Chen X, Wang B, Li L, et al
    Trim45 promotes the occurrence and development of cervical cancer by inhibiting the cGAS/STING signaling pathway.
    Integr Biol (Camb). 2026;18:zyag009.
    PubMed    
    Abstract available
    
    

47. BADAWY N, Alwadaany B, Safar H, Alshammaa M, et al
    Knowledge and attitudes regarding cervical cancer among adult Kuwaiti women: A cross-sectional study.
    Sci Rep. 2026 May 25. doi: 10.1038/s41598-026-53363.
    PubMed    
    Abstract available
    
    

48. XIE Z, Di L, He X, Huang M, et al
    DNAJC9 promotes cervical cancer cell proliferation by regulating GLI1 expression.
    Acta Biochim Biophys Sin (Shanghai). 2026;58.
    PubMed    
    Abstract available
    
    

49. ZHANG T, Zhu J, Geng L, Jin Z, et al
    FABP5 confers resistance to drug-induced ROS toxicity in cervical cancer cell lines by suppressing the PPARgamma/CPT1A signaling pathway.
    Discov Oncol. 2026 May 25. doi: 10.1007/s12672-026-05268.
    PubMed    
    Abstract available
    
    

50. LEE SS, Weil CR, Boyd L, Burt LM, et al
    Trends in Intensity Modulated Radiation Therapy Utilization for Definitive Treatment of Intact Cervical Cancer, 2004-2019.
    Adv Radiat Oncol. 2026;11:102043.
    PubMed    
    Abstract available
    
    

51. LI Z, Pang X, Wang Z, Wen J, et al
    PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report.
    Front Immunol. 2026;17:1826847.
    PubMed    
    Abstract available
    
    

52. WESSEL L, Arians N
    Postoperative proton therapy in uterine and cervical cancer: promising evidence but remaining questions.
    Transl Cancer Res. 2026;15:346.
    PubMed    
    
    
    

53. PAN H, Bao L, Shi W, Wan J, et al
    RNF112 mediates immunosuppression to inhibit the proliferation of cervical cancer by Foxm1.
    Transl Cancer Res. 2026;15:317.
    PubMed    
    Abstract available
    
    

54. GIANNECCHINI GV, Filgueiras ABT, de Andrade DAP, de Melo AC, et al
    Do ethnic differences influence the response to immunotherapy in advanced cervical cancer?
    Transl Cancer Res. 2026;15:350.
    PubMed    
    
    
    

55. CAO L, Zhang C
    A novel programmed-cell-death-related prognostic risk model for cervical cancer based on mitochondrial genes.
    Transl Cancer Res. 2026;15:271.
    PubMed    
    Abstract available
    
    

56. LI P, Shao Y, Wang J, Lin R, et al
    Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression.
    PeerJ. 2026;14:e21255.
    PubMed    
    Abstract available
    
    

57. CHEN H, She C, Wang Z, Huang X, et al
    A ferroptosis-related lncRNAs risk score model identifies LINC02178 as a potential regulator of ferroptosis sensitivity in cervical cancer.
    Front Oncol. 2026;16:1807953.
    PubMed    
    Abstract available
    
    

58. SHINDE P, Ak A, Agarwal P, Kamalnath J, et al
    Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy-results from preclinical in-silico dose comparison and quality assurance.
    Br J Radiol. 2026 May 21:tqag075. doi: 10.1093.
    PubMed    
    Abstract available
    
    

59. XUE L, Li X, Guo X, Xing H, et al
    Clinical research progress and challenges of vaccine for human papillomavirus-associated cancers.
    Hum Vaccin Immunother. 2026;22:2676391.
    PubMed    
    Abstract available
    
    

60. FRUHAUF F, Fischerova D, Moro F, Kocian R, et al
    Prospective comparison of diagnostic accuracy of ultrasound, PET/CT and DW-MRI for preoperative assessment of pelvic lymph nodes in cervical cancer patients: results of the CANNES trial.
    Ultrasound Obstet Gynecol. 2026 May 24. doi: 10.1002/uog.70241.
    PubMed    
    Abstract available
    
    

61. RATHOD G, Parmar P
    HPV self-sampling in low-resource settings: An overlooked opportunity for cervical cancer screening.
    Trop Doct. 2026 May 24:494755261454018. doi: 10.1177/00494755261454018.
    PubMed    
    Abstract available
    
    

62. WOLDEAREGAY HG, Abebe GG, Weldemariam S, Tesfay FG, et al
    Cervical cancer screening among HIV-positive women in conflict-affected and resource limited settings: the case of Tigray region, Ethiopia.
    J Health Popul Nutr. 2026 May 23. doi: 10.1186/s41043-026-01331.
    PubMed    
    Abstract available
    
    

63. LOGANATHAN T, Madhulekha S, Zayed H, C GPD, et al
    Identification of common hub genes and pathways in systemic lupus erythematosus and cervical cancer using bioinformatics approach.
    Adv Protein Chem Struct Biol. 2026;152:103-121.
    PubMed    
    Abstract available
    
    

64. M TMS, S P, Selvasudha N, Sivadas S, et al
    Plumbagin-PLA- chitosan nanoformulation ameliorates inflammation in cervical cancer (SiHa) cells by enhancing bioavailability and targeted drug delivery.
    J Biomater Sci Polym Ed. 2026 May 23:1-26. doi: 10.1080/09205063.2026.2676164.
    PubMed    
    Abstract available
    
    

65. GOVARTHAN PK, Agastinose Ronickom JF, Swaminathan R
    Identification of Cervical Cancer Biomarkers Using Gene Co-Expression Networks and Machine Learning Methods.
    Stud Health Technol Inform. 2026;336:398-402.
    PubMed    
    Abstract available
    
    

66. TSUI J, Garcia S, Shin MB, Lui K, et al
    Building capacity for equitable cervical cancer screening and follow-up in an FQHC-NCI cancer center partnership: a mixed-methods study of multilevel implementation determinants.
    BMC Prim Care. 2026 May 22. doi: 10.1186/s12875-026-03387.
    PubMed    
    Abstract available
    
    

67. AGGARWAL A, Rolland P, Leung E, Morrison J, et al
    Sentinel Lymph Node Sampling in Early-Stage Cervical Cancer: A Cross-Sectional Survey.
    BJOG. 2026 May 22. doi: 10.1111/1471-0528.70268.
    PubMed    
    
    
    

68. ABOELNASR LS, Patel J, Thomson AR, Yazbek J, et al
    Concurrent uterine and pelvic angiolipoleiomyomas.
    BMJ Case Rep. 2026;19:e270120.
    PubMed    
    Abstract available
    
    

69. ILGEN O, Karatasli V
    RETROPERITONEAL SENTINEL LYMPH NODE DISSECTION USING VNOTES IN EARLY-STAGE CERVICAL CANCER: A CASE REPORT.
    J Minim Invasive Gynecol. 2026 May 21:S1553-4650(26)00283.
    PubMed    
    Abstract available
    
    

70. JIA Z, Zhang J, Liu X, Liu C, et al
    ISG15 drives cervical cancer progression by hyperactivating the NOD-like receptor signaling pathway.
    Cancer Genet. 2026;306-307:1-6.
    PubMed    
    Abstract available
    
    

71. VANICHBUNCHA T, Leetanaporn K, Hanprasertpong J
    Impact of the diagnosis-surgery interval on survival outcomes and development of a nomogram for predicting survival in early-stage cervical cancer: a Surveillance, Epidemiology, and End Results database analysis.
    J Gynecol Oncol. 2026 May 14. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available
    
    

72. ZHANG H, Zhou H, Li M, Mutailipu T, et al
    Comparison of mRNA-based and next-generation sequencing HPV assays in a population-based cervical cancer screening program in China.
    J Gynecol Oncol. 2026 May 18. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available
    
    

73. HU Y, Chen S, Cheng H, Han Y, et al
    Chemotherapy plus camrelizumab for fertility preservation (NACI-F) in FIGO stage IB1 cervical cancer: a multicenter, single-arm, phase 2 trial.
    J Gynecol Oncol. 2026 Apr 29. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available
    
    

74. PAFENG J, Celaya A, Gay S, Fuentes D, et al
    RADIANT: A fully configurable radiotherapy dose prediction framework.
    Biomed Phys Eng Express. 2026;12.
    PubMed    
    Abstract available
    
    

75. ZHOU Q, Du H, Gao Y, Zhang Q, et al
    Baicalin induces ferroptosis in cervical squamous cell carcinoma via the NRF2/SLC7A11/GPX4 signaling axis.
    Biochem Biophys Res Commun. 2026;822:153876.
    PubMed    
    Abstract available
    
    

76. SARRIA H, Bernal G
    Prevalence of human papillomavirus in the public health system of the central-northern region of Chile.
    Diagn Microbiol Infect Dis. 2026;116:117451.
    PubMed    
    Abstract available
    
    

77. LAL S, Pradhan A, Sherpa ML
    "HPV 16/18 E6 DNA and mRNA expression in gross cervical lesions: A hospital based cross-sectional study from Sikkim, India".
    Cancer Treat Res Commun. 2026;47:101209.
    PubMed    
    Abstract available
    
    

78. WANG X, Xu J, Zhang H, Qu P, et al
    Integrating the Silva pattern into clinical practice: a prognostic tool for tailoring surgery and adjuvant therapy in cervical adenocarcinoma.
    Cancer Treat Res Commun. 2026;47:101187.
    PubMed    
    Abstract available
    
    

79. DE WAARD J, Bhattacharya A, de Boer MT, van Hemel BM, et al
    Clinical validation of a three-marker methylation panel to detect CIN3+ in vaginal self-samples in the Dutch population-based screening programme.
    Clin Epigenetics. 2025;18:97.
    PubMed    
    Abstract available
    
    

80. SMIT F, Braggion A, Cullati S, Chiolero A, et al
    Cancer screening after the age of 75: Nationwide population-based trends.
    J Med Screen. 2026;33:122-126.
    PubMed    
    Abstract available
    
    

81. MUNJAL V, Schupack KM, Miller NE, Boswell CL, et al
    Retrospective analysis of clinician and patient factors associated with unsatisfactory Pap tests.
    J Med Screen. 2026;33:94-99.
    PubMed    
    Abstract available
    
    

82. ANDERSSON H, Nordqvist Kleppe S, Edvardsson H, Elfstrom KM, et al
    Quality indicators for cervical screening in Sweden.
    J Med Screen. 2026;33:84-93.
    PubMed    
    Abstract available
    
    

83. NAIDOO L, Nxele S, Yusuf-Saka T
    Enhancing cervical cancer screening coverage in selected primary healthcare sites using Lean thinking: The CerviScreen programme.
    S Afr Med J. 2026;116:e3654.
    PubMed    
    Abstract available
    
    

84. ANGELILLO S, Miraglia Del Giudice G, Della Polla G, Angelillo IF, et al
    Cervical cancer and screening: Knowledge, attitudes, and adherence among university students in Italy.
    Hum Vaccin Immunother. 2026;22:2682535.
    PubMed    
    Abstract available
    
    

85. XU M, Kang K, Zhao M, Bi S, et al
    Optimizing ovarian dose sparing for young cervical cancer patients after oophoropexy: a dosimetric and radiobiological comparison of three radiotherapy techniques (IMPT, TOMO, and VMAT).
    Radiat Oncol. 2026 Jun 4. doi: 10.1186/s13014-026-02862.
    PubMed    
    Abstract available
    
    

86. ZOU Z, Zhai B
    A systematic review of barriers to cervical cancer screening among Thai women based on the social ecological model: a multi-level analysis of local evidence.
    Sex Health. 2026;23:SH26059.
    PubMed    
    Abstract available
    
    

87. WENG X, Zeng C, Lv J, Huang F, et al
    Exosomes derived from M2-polarized tumor-associated macrophages contribute to immune escape in cervical cancer.
    Biochem Biophys Res Commun. 2026;828:154046.
    PubMed    
    Abstract available
    
    

88. FAROOQI AA, Attar R, Gasparri ML, Berardi R, et al
    Emerging landscape of oncogenic signaling pathways in cervical cancer.
    Discov Oncol. 2026 Jun 4. doi: 10.1007/s12672-026-05271.
    PubMed    
    Abstract available
    
    

89. BOTO T, Feketshane AM, Ngxola N
    Evaluating knowledge and awareness of cervical cancer, human papillomavirus and human papillomavirus vaccination among women in East London, South Africa.
    Afr J Prim Health Care Fam Med. 2026;18:e1-e6.
    PubMed    
    Abstract available
    
    

90. WANG T, Zheng X, Chen B, Xiao R, et al
    Exploring the celecoxib-cervical cancer relationship using in vitro, network pharmacology, and Mendelian randomization approaches.
    Front Med (Lausanne). 2026;13:1777235.
    PubMed    
    Abstract available
    
    

91. GARIN C, Daix M, Bresson L, Navarro AS, et al
    Step-by-step type III total pelvic exenteration with vaginectomy and partial vulvectomy with complex pelvic reconstruction for vaginal recurrence of cervical cancer.
    Gynecol Oncol Rep. 2026;65:102109.
    PubMed    
    
    
    

92. SELVA RAJAN R, Dass SA, Sachit BA, Tye GJ, et al
    Development of a new diagnostic tool for detecting cervical cancer using a TCR-like antibody targeting the HPV 16 oncoprotein E7.
    Eur Rev Med Pharmacol Sci. 2026;30:164-180.
    PubMed    
    Abstract available
    
    

93. LIU T, Chen J, Dai B, Du D, et al
    TRIM71 suppresses cervical cancer progression by inhibiting Nectin4-mediated Wnt/beta-catenin signaling.
    Biol Direct. 2026 Jun 3. doi: 10.1186/s13062-026-00843.
    PubMed    
    Abstract available
    
    

94. AKAGAWA J, Sera T, Yuasa Y
    [Impact of Source Position Error in Tandem-ovoid Applicator on Dose Distribution in Cervical Cancer Brachytherapy].
    Nihon Hoshasen Gijutsu Gakkai Zasshi. 2026;82.
    PubMed    
    Abstract available
    
    

95. MURPHY EC, Rowen TS
    Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.
    Obstet Gynecol Clin North Am. 2026;53:339-351.
    PubMed    
    Abstract available
    
    

96. PAPENBURG J, Pollock K, Yansouni CP
    Increasing participation in cervical cancer screening.
    BMJ. 2026;393:e353462.
    PubMed    
    
    
    

97. LI B, Liu Y, Pan Y, Zhang Y, et al
    Dnq-unet: a two-level fusion framework for few-shot domain adaptation in cervical cancer CTV segmentation.
    Radiol Phys Technol. 2026 Jun 3. doi: 10.1007/s12194-026-01072.
    PubMed    
    Abstract available
    
    

98. TANG Y, Ning L, Yang X, Li N, et al
    Construction and validation of a novel prognostic risk model in cervical cancer: integrating lactylation-related genes linked to radiotherapy?associated transcriptional changes.
    Discov Oncol. 2026 Jun 3. doi: 10.1007/s12672-026-05351.
    PubMed    
    Abstract available
    
    

99. 
    Statement of Retraction: Amygdalin Induces Apoptosis in Human Cervical Cancer Cell Line HeLa Cells.
    Immunopharmacol Immunotoxicol. 2026 Jun 3:1. doi: 10.1080/08923973.2026.2675070.
    PubMed    
    
    
    

100. BILEK Y, Hakki Sarpun I, Koca T
     Can volumetric arc therapy be an alternative to brachytherapy in advanced cervical cancer radiotherapy?
     Radiat Prot Dosimetry. 2026;202:720-725.
     PubMed    
     Abstract available
     
     

101. MANIYAR AI, Alva RC, Koushik K, Nithyanand S, et al
     Enhancing brachytherapy in cervical cancer: Initial dosimetric experience and assessment of Tulip hybrid applicator - the Add-On advantage.
     J Contemp Brachytherapy. 2026;18:32-39.
     PubMed    
     Abstract available
     
     

102. MOUSSAVOU-BOUNDZANGA P, Ambounda NL, Zinsou BE, Bivigou-Mboumba B, et al
     Breast and cervical cancer screening in a semi-urban African setting: evidence from Franceville, Gabon (2015-2021).
     Front Oncol. 2026;16:1735802.
     PubMed    
     Abstract available
     
     

103. WANG Y, Jin X, Zhao S, Zhang Z, et al
     Trajectory changes of symptom clusters in patients with concurrent chemoradiotherapy for cervical cancer: a prospective longitudinal study.
     Front Oncol. 2026;16:1808208.
     PubMed    
     Abstract available
     
     

104. ZHANG L, Mwita CJ, Soliman GA, Mushi DF, et al
     Nutritional status of patients diagnosed with cervical cancer in Tanzania.
     BMC Nutr. 2026 Jun 2. doi: 10.1186/s40795-026-01323.
     PubMed    
     Abstract available
     
     

105. BAYKEMAGN ND, Alemu GG, Tewelgne MF, Bicha AT, et al
     Predicting knowledge of cervical cancer screening among reproductive-age women in sub-saharan africa using machine learning algorithms.
     Sci Rep. 2026 Jun 2. doi: 10.1038/s41598-026-54976.
     PubMed    
     Abstract available
     
     

106. BOGART LM, Whitaker L, Gwokyalya V, Beyeza-Kashesya J, et al
     A Qualitative Analysis of Factors Contributing to Cervical Cancer Screening Implementation in Health Care Facilities in Uganda.
     Cancer Control. 2026;33:10732748261450722.
     PubMed    
     Abstract available
     
     

107. HUANG L, Feng W, Long W, Liu H, et al
     Nobiletin attenuates self-renewal in cervical cancer cells and spheres through miR-342-3p upregulation and FOXM1 downregulation.
     Mol Cell Biochem. 2026 Jun 2. doi: 10.1007/s11010-026-05572.
     PubMed    
     Abstract available
     
     

108. NOORANI S, Tang KS, Patel A, Tran D, et al
     Cancerous Arrhythmia: Metastatic Cervical Cancer to the Heart Complicated by Ventricular Tachycardia.
     JACC Case Rep. 2026 Jun 2:108560. doi: 10.1016/j.jaccas.2026.108560.
     PubMed    
     Abstract available
     
     

109. BROWN C, McNally GA
     The Role of Oncology Nurses in National Breast and Cervical Cancer Screening Programs.
     Clin J Oncol Nurs. 2026;30:231-235.
     PubMed    
     Abstract available
     
     

110. MILLS D, Sridharan S, Govindarajulu G
     Cervical Cancer in Australia: A Radiation Oncology Perspective on Recent Developments, Challenges and Future Directions.
     J Med Imaging Radiat Oncol. 2026 Jun 2. doi: 10.1111/1754-9485.70130.
     PubMed    
     Abstract available
     
     

111. YOSHIMURA T, Tatsuta I, Suzuki T, Tsuchino Y, et al
     Feasibility and Short-Term Outcomes of an endoCUT-Based Non-Ligation Cervical Conization Strategy: A Single-Center Retrospective Study.
     J Obstet Gynaecol Res. 2026;52:e70349.
     PubMed    
     
     
     

112. GU X, Shen T, Guo XK
     Concerns Regarding Folic Acid in the Prevention and Treatment of Cervical Cancer.
     Nutr Rev. 2026 Jun 2:nuag096. doi: 10.1093.
     PubMed    
     
     
     

113. HUA Y, Li Y, Qin H, Huo M, et al
     Author's Reply: Letter to the Editor: Concerns Regarding Folic Acid in the Prevention and Treatment of Cervical Cancer.
     Nutr Rev. 2026 Jun 2:nuag097. doi: 10.1093.
     PubMed    
     
     
     

114. ZHAO G, Al Ramadhan MM, Zhang Y
     Prognostic value of lymphocyte to monocyte ratio for cervical cancer: a systematic review and meta-analysis.
     PeerJ. 2026;14:e21337.
     PubMed    
     Abstract available
     
     

115. PASSARELLA G, Vella S, Ferrario E, Provinciali N, et al
     Case Report: Neurological immune-related adverse events with anti-PD-1 based immunotherapy in cervical cancer.
     Front Oncol. 2026;16:1796299.
     PubMed    
     Abstract available
     
     

116. WANG Q, Li Y, Shen L, Zhang Y, et al
     Prediction of myelosuppression risk in postoperative cervical cancer patients undergoing concurrent chemoradiotherapy using machine learning models.
     Front Oncol. 2026;16:1800585.
     PubMed    
     Abstract available
     
     

117. MANGA SM, Randolph I, Ugwu L, Lee G, et al
     Nurse-led visual triage against histopathology in a real-world low-resource setting cervical cancer prevention program.
     Gynecol Oncol Rep. 2026;65:102105.
     PubMed    
     Abstract available
     
     

118. SHAH S, Shah D, Shah H, Parmar J, et al
     Outcomes of Pelvic Exenteration for Recurrent or Persistent Cervical Cancer: Revisiting Curative approach in the Era of Advancing Palliative Options.
     Indian J Surg Oncol. 2026;17:1045-1051.
     PubMed    
     Abstract available
     
     

119. RAJU K, Kukkamgai HM, Kamarthi PP
     Evolution of Cervical Cancer Screening Techniques: A Concept of Translation Medicine.
     Indian J Surg Oncol. 2026;17:1159-1170.
     PubMed    
     Abstract available
     
     

120. KAO PY, Chen JH, Chen KH
     The Role of HPV and Hormone in Cervical Precancer and Cancer: Molecular Pathophysiology and Cell Biology of Disease and Treatment.
     Oncol Res. 2026;34:12.
     PubMed    
     Abstract available
     
     

121. CHEN X, Xue Z, Zhao S, Sun L, et al
     Clinical manifestations and ultrasonographic features of lobular endocervical glandular hyperplasia: a retrospective study of 135 patients.
     Ann Med. 2026;58:2673627.
     PubMed    
     Abstract available
     
     

122. FERLA S, De Gobbi V, Seracchioli R, Raimondo D, et al
     Laparoscopic cervical cerclage at 10 weeks gestation in a patient with an adverse obstetric history following fertility-sparing surgery for cervical cancer.
     Facts Views Vis Obgyn. 2026 Jun 1. doi: 10.52054/FVVO.2026.
     PubMed    
     Abstract available
     
     

123. BISCHOF K, Fredriksen KM, Bjornstad M, Elstrand MB, et al
     Oncological outcome and immune-checkpoint-blockade-induced toxicities in patients with cervical cancer - a Norwegian real-world cohort.
     Acta Oncol. 2026;65:518-524.
     PubMed    
     Abstract available
     
     

124. ZHENG X, Pan D, Lin J, Xiao J, et al
     Analysis of Pathological Discrepancies Between Colposcopic Biopsy and Conization in Cytology-Positive Cervical Lesions.
     Cancer Med. 2026;15:e72002.
     PubMed    
     Abstract available
     
     

125. XU S, Zou Y, Wu Z, Xu Z, et al
     Deep learning-based cervical cancer T-staging using MRI: multi-structure segmentation and classification.
     BMC Med Imaging. 2026 May 30. doi: 10.1186/s12880-026-02449.
     PubMed    
     Abstract available
     
     

126. MARZHOSEYNI Z, Shayestehpour M, Shaghaghi Z, Alvandi M, et al
     Streptococcus-derived CpsA-CpsC fusion protein induces apoptosis in cervical cancer cells through in silico and in vitro methods.
     Sci Rep. 2026 May 30. doi: 10.1038/s41598-026-55464.
     PubMed    
     Abstract available
     
     

127. DIAZ-OBREGON D, Paco-Fernandez M, Ladera-Castaneda M, Huamani-Contreras M, et al
     Implementation of HPV Self-Sampling in Cervical Cancer Screening Programs: A Bibliometric Analysis of Research Output, Global Trends, and Collaboration Networks.
     Biomed Res Int. 2026;2026:e9345778.
     PubMed    
     Abstract available
     
     

128. HAMID MR, Mohd Yunus N, Abdul Aziz AA, Azwari Annuar A, et al
     Genetic polymorphisms of XRCC1 on cervical cancer susceptibility risk.
     Med J Malaysia. 2026;81:356-361.
     PubMed    
     Abstract available
     
     

129. NOVIANTI L, Calvin D, Feharsal Y, Candrani FVD, et al
     Cervical cancer survival rate after abdominal vs. laparoscopic radical hysterectomy in two government hospitals in Jakarta, Indonesia.
     Med J Malaysia. 2026;81:337-342.
     PubMed    
     Abstract available
     
     

130. HAMAD RS, Doghish AS, Abdel Mageed SS, Rizk NI, et al
     MicroRNAs in HPV-Associated Carcinogenesis: Potential Biomarkers in Oropharyngeal and Cervical Cancers.
     IUBMB Life. 2026;78:e70117.
     PubMed    
     Abstract available
     
     

131. ANTANO-ARIAS R, Torres-Rojas FI, Campos-Viguri GE, Arizmendi-Izazaga A, et al
     miR-19a-3p as a Candidate oncomiRNA in Cervical Cancer: Insights From a Bioinformatic Analysis.
     Front Biosci (Landmark Ed). 2026;31:51227.
     PubMed    
     Abstract available
     
     

132. SUGAWARA M, Nishio H, Iwata T, Katoh Y, et al
     Establishment and genomic characterization of patient-derived organoids from gastric-type cervical adenocarcinoma.
     J Gynecol Oncol. 2026;37:e101.
     PubMed    
     Abstract available
     
     

133. STEFANOS R, Gargano JW, Niccolai LM, Castilho JL, et al
     Decreases in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers: HPV-IMPACT, 2008 to 2019.
     Cancer Epidemiol Biomarkers Prev. 2026;35:913-920.
     PubMed    
     Abstract available
     
     

134. KESHARWANI P, Nasir N, Wahab S, Gupta G, et al
     PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment.
     Cancer Sci. 2026 Mar 31. doi: 10.1111/cas.70361.
     PubMed    
     Abstract available
     
     

135. IVERSEN L, Raja EA, Nath M, Lip G, et al
     The influence of rural residency on the uptake of screening for breast, cervical, and colorectal cancers in Scotland.
     J Public Health (Oxf). 2026;48:467-476.
     PubMed    
     Abstract available
     
     

136. IRIE G, Kobayashi Y, Shikama A, Yoshino M, et al
     Utility of iRECIST for evaluating treatment efficacy in patients receiving immune checkpoint inhibitors.
     J Gynecol Oncol. 2026;37:e47.
     PubMed    
     Abstract available
     
     

137. WEI S, Li X, Liu Z, Wei L, et al
     Nimotuzumab plus concurrent chemoradiotherapy sequential maintenance treatment for locally advanced cervical squamous cell carcinoma (NOTABLE-306): a multicenter, prospective, randomized, double-blind, placebo-controlled trial.
     J Gynecol Oncol. 2026;37:e46.
     PubMed    
     Abstract available
     
     

138. NAKAZAWA M, Teramoto M, Saito T
     Therapeutic efficacy of laser vaporization and conization for high-grade cervical intraepithelial neoplasia.
     J Gynecol Oncol. 2026;37:e34.
     PubMed    
     Abstract available
     
     

139. CHIKAZAWA K, Fujimori A, Imai K, Ko H, et al
     Laparoscopic radical hysterectomy after the LACC trial, avoiding uterine manipulator, pre-colpotomy vaginal washing and clamping, and uterine removal using a retrieval bag: a retrospective study.
     J Gynecol Oncol. 2026;37:e40.
     PubMed    
     Abstract available
     
     

140. HARGIS A, Berg CJ, Le D
     Knowledge, Attitudes, and Behaviors Regarding HPV Vaccination and Self-Sampling Among US Young Adults.
     J Cancer Educ. 2026;41:588-600.
     PubMed    
     Abstract available
     
     

141. KYLLONEN S, Saloranta S, Kares S, Mustila A, et al
     Introducing self-sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland.
     Acta Obstet Gynecol Scand. 2026 Jun 4. doi: 10.1111/aogs.70273.
     PubMed    
     Abstract available
     
     

142. ELLIS LB, Tighe J, Bowden SJ, Kechagias KS, et al
     Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis.
     Eur J Cancer. 2026;243:116823.
     PubMed    
     Abstract available
     
     

143. WOLSWINKEL JT, Bekkers AHPA, Maurits JSF, Bekkers RLM, et al
     Preoperative LVSI assessment in early-stage cervical cancer: Can it reliably guide lymph node management?
     Gynecol Oncol. 2026;210:106-112.
     PubMed    
     Abstract available
     
     

144. RUSSELL JC, Amin S, Kohler RE, Kelly H, et al
     Understanding barriers to cervical cancer screening in Botswana: Insights from a cross-sectional study.
     Int J Gynaecol Obstet. 2026 May 26. doi: 10.1002/ijgo.71089.
     PubMed    
     Abstract available
     
     

145. TJOKROPRAWIRO BA
     TeleDoIVA: expanding cervical cancer screening across Indonesia's Archipelago through smartphone-based teleconsultation.
     Int J Gynecol Cancer. 2026 Apr 25:104723. doi: 10.1016/j.ijgc.2026.104723.
     PubMed    
     
     
     

146. TEODORICO E, Moro F, Criscione M, Culcasi C, et al
     Ultrasound detection of residual cervical cancer after conization, in a retrospective monocentric analysis: the URECA study.
     Int J Gynecol Cancer. 2026;36:104755.
     PubMed    
     Abstract available
     
     

147. LEVIN G, Gilbert L, Pareja R, Leung SOA, et al
     Impact of bilateral oophorectomy on survival among patients undergoing radical hysterectomy for cervical adenocarcinoma: a National Cancer Database analysis.
     Int J Gynecol Cancer. 2026;36:104469.
     PubMed    
     Abstract available
     
     

148. MAYADEV J, Deng W, Kim H, Xiao Y, et al
     Radiation Quality and Workflow in NRG GY017: Anti PD-L1 (Atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer.
     Int J Radiat Oncol Biol Phys. 2026 May 24:S0360-3016(26)00706.
     PubMed    
     Abstract available
     
     

149. CHARNALIA M, Ranjan N, Spampinato S, Nout R, et al
     Cumulative gastrointestinal adverse events in EMBRACE-I: comparative evaluation of CTCAE vs. MOSES methods in predicting the impact of incident vs. persistent adverse events on quality of life.
     Radiother Oncol. 2026;219:111489.
     PubMed    
     Abstract available
     
     

150. DUDUYEMI BM, Mensah BNO, Addae EK, Sallah L, et al
     Expression of p16 and p53 proteins in cervical cancer cases in a tertiary centre in Ghana: an immunohistochemical study.
     BMC Cancer. 2026 May 27. doi: 10.1186/s12885-026-16266.
     PubMed    
     Abstract available
     
     

151. HE Y, Yang H, Zhang C, Jiang R, et al
     Identification and validation of CNTNAP2/PAX1 hypermethylation as an epigenetic biomarker panel for detection of cervical cancer and precancerous lesions in hrHPV-positive women.
     BMC Cancer. 2026 May 22. doi: 10.1186/s12885-026-16208.
     PubMed    
     Abstract available
     
     

152. BUTTA J, Thonghoi P, Kesakul T, Thoopthong A, et al
     Incremental impact of community-delivered HPV self-sampling on screening uptake within an active outreach system: A quasi-experimental implementation study in rural Thailand.
     PLoS One. 2026;21:e0349531.
     PubMed    
     Abstract available